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Abstract
Background—Delirium is common in post-acute care (PAC) patients with dementia; its 
treatment is not established. We hypothesized that cognitively-stimulating activities would reduce 
the duration and severity of delirium and improve cognitive and physical function to a greater 
extent than usual care.
Design—Single-blind randomized clinical trial.
Setting—eight PAC facilities.
Participants—283 community-dwelling older adults with dementia and delirium.
Intervention—Cognitively-stimulating activities delivered daily for up to 30 days.
Measurements—Primary outcomes were delirium duration (Confusion Assessment Method), 
and delirium severity (Delirium Rating Scale). Secondary outcomes were cognitive function 
(Digits Forward, Montreal Cognitive Assessment and CLOX) and physical function (Barthel 
Index).
Results—Mean percentage of delirium-free days were similar in both groups: 64.8% (95% CI: 
59.6–70.1) (intervention) vs. 68.7% (95% CI: 63.9–73.6) (control), p = 0.37, Wilcoxon's rank 
sums test. Delirium severity was similar in both groups: 10.77 (95% CI: 10.10–11.45) 
(intervention) vs. 11.15 (95% CI: 10.50–11.80) (control), a difference of 0.37 (95% CI: 0.56–1.31, 
p= 0.43). Significant differences for secondary outcomes favoring intervention were found: 
executive function: 6.58 (95% CI: 6.12–7.04) vs. 5.89 (95% CI: 5.45–6.33), a difference of −0.69 
(95% CI: 1.33– −0.06, p=0.03); and constructional praxis: 8.84 (95% CI: 8.83–9.34) vs. 7.53 (95% 
CI: 7.04–8.01), a difference of − 1.31 (95% CI: 2.01– −0.61, p=0.0003). After adjusting for 
baseline constructional praxis the group comparison was no longer significant. Average length of 
stay was shorter in intervention (36.09 days vs. 53.13 days, SE = 0.15, p = 0.01, negative binomial 
regression).
Conclusion—Cognitively-stimulating activities did not improve delirium but did improve 
executive function and reduced length of stay. Resolution of delirium may require more intense 
non-pharmacological management when the patient has dementia.
Keywords
Delirium; Dementia; Post-acute Care; Non-pharmacological Intervention
INTRODUCTION
Delirium is a state of confusion characterized by an acute decline in cognitive function.1 It is 
common and deadly in older adults with dementia.2 The effects of delirium persist long after 
Kolanowski et al. Page 2
J Am Geriatr Soc. Author manuscript; available in PMC 2017 December 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
hospitalization3, 4 and manifest as worsening global cognition.5 Discharges to post-acute 
care (PAC) following a hospitalization have risen sharply in recent years. Because of the 
temporal proximity to medical illness, these settings carry a high delirium burden that if 
unresolved, reduces rehabilitation potential,6 accounts for high medical costs,7 and predicts 
new institutionalization.8 It is important to determine if intervening on delirium in PAC can 
improve clinical outcomes for patients at highest risk for poor outcomes, those with delirium 
superimposed on dementia (DSD).3
The treatment of delirium is not established. Current practice is directed toward symptom 
management using antipsychotic or sedative medications.1 These medications carry an 
increased risk for adverse outcomes in patients with dementia and may actually prolong the 
duration of delirium.1 Multi-component non-pharmacological interventions that modify 
delirium risk factors are efficacious for prevention,9 but the evidence for their efficacy in 
treatment is lacking,10 although they are recommended in current guidelines.11 With few 
exceptions, there is no indication that the individual components making up these 
interventions were implemented in a consistent fashion, or in a “dose” that was likely to 
produce an effect. Because there is no widely accepted intervention for delirium,12 we 
sought to determine whether our theoretically-based, non-pharmacological intervention 
would demonstrate efficacy for the symptom management of DSD. Because delirium 
resolution may be independent of improvements in specific cognitive domains,13 we also 
examined these outcomes.
Our intervention uses individualized cognitively-stimulating activities to restore the 
disrupted cognitive function that is found in delirium regardless of precipitating cause.14 
Several lines of evidence support a strong relationship between delirium and dementia;1, 15 
interventions that improve symptoms in one of these conditions may also be effective in the 
other. For example, cognitive stimulation therapy can improve cognitive function in 
dementia.16 In our pilot work we found that PAC patients with DSD who engaged daily in 
cognitively-stimulating activities had less decline in global cognition and physical function 
compared to the control group.17 Cognitive stimulation is often one component of 
efficacious delirium prevention protocols, although its independent effects are not know and 
much of this research did not include patients with dementia.9 In a recent clinical trial, an 
intervention of combined cognition-focused and physical therapy improved executive 
function and instrumental activities of daily living in cognitively impaired survivors of 
critical illness when compared to physical therapy only.18
We hypothesized that individualized cognitively-stimulating activities would reduce the 
duration and severity of delirium and improve cognitive and physical function in PAC 
patients with DSD to a greater extent than usual care.
METHODS
In this single-blind clinical trial we enrolled 283 patients who were admitted to PAC settings 
following a hospitalization between February, 2011 and October, 2014. Follow-up was 
completed in January, 2015. Written consent was obtained prior to enrollment in the study. 
The study was approved by the Penn State institutional review board, was registered 
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(ClinicalTrials.gov identifier: NCTO1267682), and had a data safety and monitoring 
committee that convened annually.
Participants
Participants were recruited at admission to one of eight PAC settings in Pennsylvania. 
Interested individuals were screened for eligibility within 72 hours of admission by trained 
research nurses.
Eligible participants were 65 years of age or older, community-dwelling prior to 
hospitalization, had a knowledgeable informant, and had both mild to moderate stage of 
dementia, and full or subsyndromal delirium. We admitted those with full or subsyndromal 
delirium because of the poor outcomes observed in both.19 The presence of dementia was 
based on a score of three or greater on the Modified Blessed Dementia Rating Scale 
(MBDRS)20 and a Clinical Dementia Rating (CDR)21 score ranging from 0.5 to 2.0. The 
presence of delirium was based on the presence of two or more positive features on the 
Confusion Assessment Method (CAM).22 All dementia and delirium diagnoses were 
adjudicated by a panel of three experts: behavioral neurologist, neuropsychologist, and 
geriatrician.
Exclusion criteria included: having any neurological, or neurosurgical disease associated 
with cognitive impairment, including Parkinson’s disease with Lewy bodies, acute stroke, 
Huntington’s disease, normal pressure hydrocephalus, seizure disorder, subdural hematoma, 
head trauma or known structural brain abnormalities; nonverbal; having a life expectancy of 
six months or less; acute major depression or psychosis; and severe hearing, or vision 
impairment.
Participants were randomly assigned to cognitive stimulation (intervention), or usual care 
(control). Randomization was concealed until after enrollment and was conducted using 
SAS Release 9.3 using randomly permuted blocks of sizes 2, 4 and 6 to ensure 
approximately balanced intervention group sizes across the length of the study, and to 
control for possible temporal effects. All outcomes were measured by trained assessors, 
blind to randomization. We maintained blinding by keeping assessment and intervention 
teams separate in the clinical area and during research team meetings. At the completion of 
the study we asked assessors if there were any instances when blinding was broken; none 
were reported.
Procedure
The study had three phases: baseline, intervention, and follow-up. Baseline assessments 
were conducted by the research nurse at enrollment. Data included: demographic 
information; mental status assessment using the Mini-Mental State Exam, a 30-item 
cognitive screen23; medical diagnoses, number of prescribed medications, including those 
with anticholinergic properties identified using the Anticholinergic Cognitive Burden 
Scale,24 and therapies obtained from the medical chart; APOE genotyping by extracting 
DNA from buccal swabs25 ; and for the intervention group, an assessment of activity 
preferences. The intervention period began within 24 hours of baseline and continued for 30 
days, or until discharge. Daily assessments of delirium, cognitive function, and physical 
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function were completed in both groups, and daily intervention sessions were conducted 
with the intervention group. We used two separate teams of trained research assistants: one 
team delivered the intervention and the other team conducted the outcome assessments. 
Phone follow-up with the participant's legally authorized representative occurred three 
months after admission and was completed by the research nurse.
Conditions
The protocol for the intervention has been published and includes a training video 
illustrating implementation.26 The goal of the intervention is to elicit active engagement in 
simple activities that provide cognitive stimulation in a non-regimented way and promote 
processing supportive of function in the domains of attention, memory, orientation and 
executive function. The PI (AK), in consultation with the neuropsychologist (LC), and the 
research nurse prescribed the activities. Fifteen activities of increasing difficulty were 
individually selected for each participant based on assessments of their leisure interests, 
physical function, and mental status. For example, if the participant was an older male with 
mild cognitive impairments, no visual impairments but some difficulty hearing, and who was 
a former high school chemistry teacher who enjoyed woodworking and movies, the 
following activities might be prescribed and delivered using a hearing amplifier: name three 
elements that are gases, metals; replicate building a block design; and identify Famous 
Faces. The match to interest and ability was done to provide intrinsic motivation for 
engagement and to capture attention,27 the most prominent domain affected by delirium. 
Activities were selected from a large database of activities previously tested in older adults 
with dementia.28 The advantage of activities, such as word searches or puzzles, is that they 
offer stimulation in multiple cognitive domains, combined in novel ways, and unobtrusively 
provide the opportunity for cognitive processing. Participants received the intervention, 
delivered by trained research assistants, in individual sessions for up to 30 minutes each day, 
five days per week for 30 days or until discharge. The dosage was based on studies that have 
demonstrated the efficacy of daily, 20-minute recreational therapy for the behavioral 
symptoms of dementia,27 and our pilot work with DSD patients.17
Prior to the activity session, the interventionists corrected any potentially confounding 
conditions (i.e., poor lighting, noise etc.). During the session they used principles for 
maximizing cognitive processing: active participation, verbal encouragement, variability in 
tasks, and increase in the level of difficulty as success occurred with simpler tasks.29 At the 
completion of the session, the activities attempted, time on task, and level of participation 
were recorded.
Treatment fidelity checks were conducted on 10% of all intervention sessions by trained 
research assistants (never members of the assessment team). These research assistants 
unobtrusively observed the assigned interventionist during the delivery of the intervention 
and rated adherence to critical aspects of treatment delivery, such as: used correct activities 
for participant; excluded extraneous/environmental factors that might influenced the delivery 
of the intervention (noise, poor lighting); and used the system of least restrictive prompts to 
engage the participant. Booster sessions for interventionists were held every three months 
Kolanowski et al. Page 5
J Am Geriatr Soc. Author manuscript; available in PMC 2017 December 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
and were conducted by the project director (PM) and the principal investigators (AK and 
DMF).
Because the management of DSD is variable across practitioners we conducted weekly 
medical chart reviews to characterize usual care: therapies attended; number of medications 
received; and number of documented nursing interventions delivered for delirium/confusion.
Outcomes
Inter-rater reliability was conducted on 10% of the outcome measures. Assessor booster 
sessions were held every three months and conducted by the project director (PM) and the 
principal investigators (AK and DMF).
Our primary outcomes were delirium duration, and severity. Secondary outcomes were 
cognitive and physical function.
Delirium duration was measured using the CAM.22 The CAM has been validated in 
dementia populations, has a sensitivity between 94% and 100%, and a specificity between 
90% and 95%.22 In this study a weighted kappa of 0.88 was obtained for inter-rater 
reliability. The CAM includes the four features of acute and fluctuating course, inattention, 
disorganized thinking, and impaired level of consciousness. In this study, the presence of 
two or more features indicated subsyndromal delirium, and the presence of features 1 and 2 
and either 3 or 4 indicated full delirium. Delirium duration was assessed in two ways: time 
to first delirium remission, i.e. the number of days until reaching two consecutive CAM 
features = 0 or 130 and percentage of total days delirium free (CAM= 0 or 1). Delirium 
severity was measured using the Delirium Rating Scale (DRS),31 a 13-item clinician-rated 
scale validated in both delirium and dementia groups,32 and having good sensitivity, 
specificity, and high interrater reliability (ICC 0.97). In this study an ICC of 0.72 was 
obtained for inter-rater reliability. Scores range from 0 to 39; higher scores indicate greater 
severity.
Cognitive function was measured with three instruments. Attention was measured using 
Digit Span Forward (range: 0 to 16). Memory (range: 0–3) and orientation (range: 0–7) were 
measured using the corresponding items from the Montreal Cognitive Assessment 
(MoCA).33 We obtained weighted kappas of 0.95, 0.96 and 0.97 for the attention, memory, 
and orientation measures, respectively. Executive function and constructional praxis were 
measured using the CLOX,34 a clock drawing task that elicits impairment in executive 
function (CLOX 1), and discriminates it from non-executive constructional failure (CLOX 
2). We obtained weighted kappas of 0.92 and 0.93 for the CLOX 1 and CLOX 2 measures, 
respectively.
Physical Function was measured using the Barthel Index (BI),35 an ordinal scale for 
assessing activities of daily living in patients receiving inpatient rehabilitation; scores range 
from 0 (totally dependent) to 100 (fully independent). In this study an ICC of 0.87 was 
obtained for inter-rater reliability.
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Other outcomes were length of stay and discharge disposition at the 3 month follow-up 
(community, nursing home, or death). The study was not powered to detect differences in 
these outcomes.
Statistical Analysis
Power to detect a difference in mean levels of severity and duration of delirium between the 
groups was estimated a priori, assuming a total sample size of 256 participants after attrition, 
and adjusting for cluster effects due to multiple observations made on the same subjects.
Assuming 30 observations per subject, and an intraclass correlation coefficient equal to 0.25, 
this sample size would provide > 99% power to detect a medium effect size, or 0.5 times the 
within-group standard deviation (sd). The difference detectable with 80% power would be 
0.185 sd.
Within-group standard deviations and effect sizes were estimated from pilot data with up to 
30 days’ observation on 16 subjects. Based on these pilot data, DRS and CAM showed 
effect sizes of 0.45, and 0.47, respectively. The study would provide at least 94%, and 96% 
power to detect the differences, respectively.
The intention-to-treat principle was used for analysis, and the statistician was blind to group 
assignment until all analyses were complete. Descriptive statistics including frequencies, 
means and standard deviations were calculated separately by intervention group. Cross-
sectional analyses of patient characteristics and other variables having a single observation 
per subject were compared between the groups using Analysis of Variance for continuous 
variables, and chi-square analysis for categorical variables. Sample distributions were 
examined for all analysis variables. Variables showing substantial deviation from normality 
were rank-transformed for analysis.
Variables having a single observation per subject were compared between the groups using 
Analysis of Variance. Normality was evaluated by analysis of residuals. Length of stay was a 
single observation per subject (i.e., count of the number of days the patient received PAC), 
and was not normally distributed (intervention skew = 3.67; control skew= 2.7). To account 
for the variable type and non-normal distribution, group comparison of length of stay was 
analyzed using a negative binomial mixed model due to the significant contribution of 
facility to these values (χ2(1) = 71.77, p < .01). For variables with multiple observations per 
subject, groups were compared using mixed linear models in order to account for 
correlations among repeated measurements made on the same individuals. Categorical 
dependent variables with multiple observations per participant were analyzed using 
generalized linear models to implement mixed-model logistic regression analysis. To 
evaluate the sensitivity of the results to this analytic choice, the primary analyses were 
repeated with the inclusion of a facility term as a blocking variable in the model. The results 
show generally slight changes in the p-values for the treatment group comparisons, and no 
statistical decision would be altered. We also adjusted the analyses for the baseline 
difference in CLOX 2 and report both unadjusted and adjusted results. Time to resolution 
was evaluated using the Kaplan-Meier product limit survival estimator. The log-rank test 
was used for comparisons between groups.
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Means and standard deviations are presented, as well as least-squares (marginal) means and 
standard errors. Means and least-squares means will be equal for the ANOVA analyses; 
least-squares means are reported in order to get estimated standard errors for comparability 
with those that are obtained from the mixed model analyses. Note that the standard 
deviations calculated for variables with more than one observation per individual include 
both between- and within-subject variation.
RESULTS
Participant flow through the study is depicted in Figure 1. A total of 17 (6%) participants 
withdrew from the study. Reasons for withdrawal were similar in both groups. Table 1 lists 
the demographic, baseline clinical characteristics, and usual care received by total sample 
and group. Baseline values for cognitive and physical function outcomes are published 
online as supplemental material. Overall, participants were elderly, white and female with 
mild to moderate dementia. The adjudication panel reached agreement on 98.9% and 100% 
of the dementia and delirium diagnoses, respectively. There were no differences between the 
groups for any demographic or clinical characteristic at baseline or usual care received with 
the exception of CLOX 2 (constructional praxis) which was significantly greater in 
intervention (p = 0.02). No adverse events were reported in either group.
Completion of outcome assessments was excellent. We obtained 92.6% and 95.3% of all 
possible CAM and DRS assessments; 86.3% and 79.1% of all possible MoCA and CLOX 
assessments; and 95.8% of all possible BI assessments. There were no differences in missing 
data between the groups, and we found no evidence that missing data were due to any 
substantive correlations with demographic, or clinical characteristics.
There was very good adherence to the intervention, and no withdrawals were due to the 
intervention itself. The intervention group participated in an average of 70.5% of the total 
sessions possible during the PAC stay. On average, 12.99 ± 8.2 intervention sessions that 
lasted for 19.1± 13.4 minutes were delivered to participants. Participation during these 
sessions was primarily active (mean= 2.7± 0.7 on 3 point scale: 3= active; 0= dozing). 
Omitted sessions were not due to any demographic, or clinical characteristics. 
Interventionists achieved between 95%, and 100% compliance on specified intervention 
delivery elements.
Outcomes
For participants with two or more PAC days, 86.3% (120/139) of intervention and 87.1% 
(122/140) of control participants experienced a remission of delirium at some point over the 
PAC stay (i.e., CAM= 0 or 1 for two or more consecutive days). Figure 2 is a graph of the 
Kaplan-Meier survival analysis depicting time to first remission by group. Intervention 
participants experienced a first remission on day 6.88 (95% CI: 6.14–7.61), and usual care 
participants on day 7.39 (95% CI: 6.47–8.31) (p=0.89, log-rank test). Despite a relatively 
early first remission, only 37.68% of intervention participants and 34.78% of usual care 
participants were in remission at discharge or completion of the intervention period. We also 
examined the mean percentage of delirium-free days and found that 64.8% (95% CI: 59.6–
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70.1) of intervention, and 68.7% (95% CI: 63.9–73.6) of control days were delirium free (p 
= 0.37, Wilcoxon's rank sums test).
Figure 3 is a graph of the mean delirium severity score (DRS) over time by group. 
Participants exhibited primarily subsyndromal delirium, defined as a score between 8 and 15 
on the DRS (10.77 (95% CI: 10.10–11.45) (intervention) vs. 11.15 (95% CI: 10.50–11.80) 
(control), a difference of 0.37 (95% CI: 0.56–1.31, p= 0.43). Full delirium was observed in 
14.47% of intervention, and 14.82% of control days.
Table 2 contains the cognitive and physical function outcomes. Statistically significant 
differences between the groups were found for executive function and constructional praxis 
(CLOX 1 and 2). They favored intervention. Cohen's effect size value for CLOX 1 (d = .19) 
suggested a small effect and for CLOX 2 (d=.32) a small to moderate effect. After adjusting 
for baseline differences in CLOX 2 the group comparison for constructional praxis was no 
longer significant. There were no differences between the groups for other cognitive 
measures or physical function.
Length of stay was non-normally distributed and depended on the facility (χ2(1) = 71.77, p 
< .01). Excluding withdrawals (n=17) and accounting for facility, the model estimated 
average length of stay was 36.09 days for intervention and 53.13 days for usual care (b = 
0.39, SE = 0.15, p = 0.01). To avoid over-interpretation of these results we examined group 
assignments in sites and found that the groups were distributed across facilities equivalently 
(Chi-sq (7) = 4.35, p = .7385). We found no differences in mortality: 20 (15.4%) deaths in 
intervention vs. 17 (12.5%) in control (p=0.61, chi square). In addition to withdrawals, 15 
participants were lost to the three-month follow-up. We examined discharge location in the 
214 participants who were alive and remained in the study at that point. More in intervention 
returned to the community [46 (32.6%) vs. 39 (27.5%)] and fewer were institutionalized [60 
(42.5%) vs. 69 (48.6%)] than in usual care, but the difference was not statistically 
significance (p= 0.54, chi square).
DISCUSSION
This is the first clinical trial to test a non-pharmacological intervention recommended in 
current guidelines for management of delirium.11 A daily 30-minute session of 
individualized cognitively-stimulating activities, delivered with high fidelity, did not 
improve delirium duration or severity. There was a small effect for executive function 
favoring intervention and intervention participants spent fewer days in PAC than control 
participants.
Most participants experienced subsyndromal delirium across PAC days and most days were 
delirium free. Delirium features, however, persisted through discharge for the majority of 
participants. In a recent prospective cohort study, Cole and colleagues found that DSD is 
more protracted than previously thought.13 The majority of patients in that study had no, or 
partial delirium recovery at three months post-enrollment, despite significant improvements 
in global cognition and function. These findings and our results underscore the need for 
longer follow-up to capture possible delayed effects of intervention on resolution of DSD.
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Few studies have investigated whether specific cognitive domains improve more than others 
under intervention for delirium. We found a small effect for executive function that favored 
intervention. This was above gains that may be attributed to rehabilitation therapies, which 
can also improve this outcome, and which the majority of both groups received.
Even the small improvement we observed in executive function may be notable given the 
underlying cognitive impairments of our participants and literature that suggests an 
association of this higher-order function with delirium pathophysiology.36, 37 In clinical 
studies, fronto-executive dysfunction independently predicted postoperative delirium even in 
the absence of cognitive impairment.38 Patients who recover from delirium have short5 and 
long-term4 impairments in executive function. Jackson and colleagues18 reported greater 
benefits for executive function using cognition-focused and physical therapy verses physical 
therapy only in ICU survivors. Unlike our study, their combined intervention continued for 
12 weeks, their subjects were younger, and none had dementia. Executive function may be a 
key cognitive domain reflecting central nervous system integrity following delirium, and the 
effect of interventions that aim to strengthen it.
In unadjusted analyses we observed a small to moderate effect for constructional praxis. 
These visual-spatial skills are important for hazard perception and deficits are found in 
patients with frontal dysfunction.39 However, after adjusting for baseline differences, the 
group comparison was no longer statistically significant.
While the intervention did not reduce delirium, it may have a role in future delirium 
prevention trials by way of strengthening important cognitive domains such as executive 
function and providing cognitive reserve as a protection against delirium risk factors. 
Impacting executive function also has implications for practice as these higher-order 
functions have importance for independence.40 In our analyses we found that groups were 
distributed equally across sites, and our length of stay analyses also controlled for the effect 
of facility on outcomes. We found that length of stay was significantly shorter in 
intervention compared to control. While there was no difference in discharge disposition, the 
ability to be transitioned more quickly to a lower-level of care represents cost savings that 
may be realized by even small effects on cognitive function. Additionally, as we discuss 
below, the outcome measures we used may not have been sensitive enough to demonstrate 
important differences between the groups attributed to the intervention. Instrument selection 
is an important issue for future research.
Attention, memory, and orientation may have been less amenable to intervention, but may 
also recover earlier, making improvement difficult to detect in PAC. Mark and colleagues5 
found that one week following recovery from delirium, hospitalized older adults' 
performance on attention, memory and orientation was similar to those who did not 
experience delirium. The delirious group, however, remained significantly worse than the 
non-delirious group on executive function, praxis, and language, and in unadjusted analyses, 
our intervention had a small effect on two of these domains.
Both groups received physical and occupational therapies which may account for the lack of 
difference on physical function. While the aggressive rehabilitation available in PAC 
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facilitates recovery, the large percentage of participants who had delirium features on 
discharge and who were admitted to long-term care (57.3% of those alive at three months) 
brings into question whether the PAC environment influences the persistence of delirium and 
higher-order cognitive symptoms.6
There are several limitations of this study. It is likely that cognition in PAC is linked to pre-
illness cognition. Because we enrolled patients at admission to PAC, we were not able to test 
functioning prior to the illness that precipitated hospitalization. We addressed this limitation 
by using the Blessed and CDR at baseline to estimate preexisting cognitive function. By 
design only individuals with DSD were eligible for the study so we do not know if the 
intervention would be more effective in those without dementia. For patients with dementia, 
the duration of the intervention and length of follow-up may need to be extended for a 
longer period than a relatively-short PAC stay. The instruments we used for measuring our 
outcomes were selected to reduce participant burden; a larger effect might be found using a 
more in-depth neuropsychological test battery.
There are also several strengths of this study. We tested a theory-based intervention in a 
population lacking research on interventions that optimize rehabilitation. We also examined 
specific cognitive domains rather than one global outcome, thus adding to the literature on 
delirium resolution.
All interventions require staff time; using only those components with known benefits will 
improve the quality and cost-effectiveness of care. Cognitive stimulation did improve 
cognition and length of stay, having implications for both quality of life and cost of care. 
Resolution of delirium may require more intense non-pharmacological management when 
the patient has dementia.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Flow of Primary Participants (N= 283) Through Study
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Figure 2. 
Time to First Remission
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Figure 3. 
Mean Delirium Severity Score
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Table 1
Demographic and Baseline Clinical Characteristics of Sample and Description of Usual Care
Variable Total Sample
(N= 283)
Intervention
(N= 141)
Control
(N= 142)
Age in years (mean ± SD) 85.78± 6.8 85.28 ±6.8 86.28 ±6.7
Gender N (%): Female 183 (64.6) 88 (62.4) 95 (66.9)
Male 100 (35.3) 53 (37.6) 47 (33.1)
Race N (%): White 276 (97.5) 136 (96.4) 140 (98.6)
Black 7 (2.4) 5 (3.6) 2 (1.4)
Education N (%)1 Grade school 14 (5.0) 5 (3.6) 9 (6.6)
Some High School 72 (26.0) 33 (23.6) 39 (28.7)
High School 107 (38.8) 61 (43.6) 46 (33.8)
Post-secondary 83 (30.0) 41 (29.3) 42 (30.9)
Marital Status N (%): Married 108 (38.2) 56 (39.7) 52 (36.6)
Widowed 148 (52.3) 70 (49.6) 78 (54.9)
Single 12 (4.2) 6 (4.3) 6 (4.2)
Separated/Divorced 15 (5.3) 9 (6.4) 6 (4.2)
  APOE status N(%)2 One e4 allele 77 (28.3) 32 (23.5) 45 (33.1)
Two e4 alleles 10 (3.7) 5 (3.7) 5 (3.7)
None 185 (68.0) 99 (72.8) 86 (63.2)
Charleson Comorbidity (mean ± SD) 3.00 ± 1.93 2.97 ± 1.9 3.0 ± 1.9
CDR (mean ± SD)3 1.25 ± 0.5 1.24 ± 0.5 1.26 ± 0.5
MMSE (mean ± SD) at admission4 13.86 ± 6.0 14.48± 6.1 13.24± 5.8
Blessed (mean ± SD)5 5.96± 2.3 6.00 ± 2.4 5.92 ± 2.3
Full Delirium on Admission N (%) 115 (40.6) 55 (39.0) 60 (42.3)
Sub-syndromal Delirium on admission N (%) 168 (59.4) 86 (60.9) 82 (57.7)
Usual Care
Therapies Received N (%): Physical 277(97.9) 139 (98.6) 138 (97.2)
Occupational 268 (94.7) 134 (95.0) 134 (94.4)
Speech 177 (62.5) 84 (59.6) 93 (65.5)
Other 8 (2.8) 3 (2.1) 5 (3.5)
Medications (mean ± SD)6
  Total prescribed (includes scheduled & as needed) 15.38 ±4.7 15.76 ±5.3 15.00 ±4.2
  Medications administered with Anticholinergic Properties (level 1, 2 & 3) 1.61 ± 1.1 1.60 ± 1.1 1.63 ±1.1
Number of Nursing Interventions for Delirium
Documented/Week (mean ± SD)
1.34 ± 3.9 1.31± 4.1 1.37 ± 3.8
1
. Missing = 7 (intervention n = 140; control n = 136)
2
. Missing = 11 (Intervention n = 136; control n = 136)
3
. Clinical dementia rating Scale (CDR)- range (for this study) 0.5–2·0
4
. Mini-Mental Status Exam (MMSE)- range = 0–30
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5
. Modified Blessed Dementia Rating Scale- range = 0–17
6
. Missing = 2 (Intervention n = 139; control n = 142)
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Table 2
Cognitive and Physical Function Outcomes by Group*
Outcome Intervention Control Unadjusted P-
value
Adjusted P-
value**
Cognition
  Attention 7.99 [0.16]
(7.69, 8.32)
7.87 [0.16]
(7·56, 8·18)
0.17 0.19
  Memory 0.78 [0.06]
(0.66, 0.92)
0.80 [0.06]
(0.69, 0.92)
0.76 0.72
  Orientation 3.47 [0.12]
(3.24, 3.69)
3.25 [0.11]
(3.03, 3.47)
0.18 0.09
Executive
Function
  CLOX 1 6.58 [0.23]
(6.12, 7.04)
5.89 [0.22]
(5.45, 6.33)
0.03 0.009
  CLOX 2 8.84 [0.26]
(8.83, 9.34)
7.53 [0.25]
(7.04, 8.01)
0.0003 0.11
Physical
Function
Barthel Index 41.64 [1.76]
(38.17, 45.11)
43.07 [1.73]
(39.67, 46.46)
0.57 0.77
*
Data are expressed as Marginal (Least Squares) Mean [standard error] (95% CI) unless otherwise indicated
**Adjusted for facility and baseline CLOX 2
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